Abanoub Riad1,2, Holger Schünemann3, Sameh Attia4, Tina Poklepović Peričić5, Marija Franka Žuljević6, Mikk Jürisson7, Ruth Kalda7, Katrin Lang7, Sudhakar Morankar8, Elias Ali Yesuf8, Mohamed Mekhemar9, Anthony Danso-Appiah10, Ahmad Sofi-Mahmudi11, Giordano Pérez-Gaxiola12, Arkadiusz Dziedzic13, João Apóstolo14, Daniela Cardoso14, Janja Marc15,16, Mayte Moreno-Casbas17, Charles Shey Wiysonge18, Amir Qaseem19, Anna Gryschek20, Ivana Tadić21, Salman Hussain1, Mohammed Ahmed Khan22, Jitka Klugarova1,2,23,24, Andrea Pokorna1,23,24, Michal Koščík2,25, Miloslav Klugar1,2,23,24. 1. Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. 2. Department of Public Health, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic. 3. Department of Health Research Methods, Evidence, and Impact, McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street West, Hamilton, ON L8N 4K1, Canada. 4. Department of Oral and Maxillofacial Surgery, Justus-Liebig-University, Klinikstrasse 33, 35392 Giessen, Germany. 5. Department of Research in Biomedicine and Health, University of Split School of Medicine, Šoltanska 2, 21000 Split, Croatia. 6. Department of Medical Humanities, University of Split School of Medicine, Šoltanska 2, 21000 Split, Croatia. 7. Department of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411 Tartu, Estonia. 8. Faculty of Public Health, Institute of Health, Jimma University, Aba Jifar 1 Street, 378 Jimma, Ethiopia. 9. Clinic for Conservative Dentistry and Periodontology, School of Dental Medicine, Kiel University, Arnold-Heller-Str. 3, Haus B, 24105 Kiel, Germany. 10. Department of Epidemiology and Disease Control, School of Public Health, University of Ghana, Accra LG 25, Ghana. 11. Cochrane Iran Associate Centre, National Institute for Medical Research Development, Tehran 16846, Iran. 12. Department of Evidence Based Medicine, Sinaloa Pediatric Hospital, Cochrane Mexico, Calle Constitución 530, Jorge Almada, 80200 Culiacán, Mexico. 13. Department of Conservative Dentistry with Endodontics, Medical University of Silesia, 40-055 Katowice, Poland. 14. Health Sciences Research Unit: Nursing, Portugal Centre for Evidence-Based Practice: JBI Centre of Excellence, Nursing School of Coimbra, 3004-011 Coimbra, Portugal. 15. Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia. 16. Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Zaloška cesta 2, 1000 Ljubljana, Slovenia. 17. Nursing and Healthcare Research Unit (Investén-isciii), Instituto de Salud Carlos III, 28029 Madrid, Spain. 18. Cochrane South Africa, South African Medical Research Council, Cape Town 7501, South Africa. 19. American College of Physicians, 190 N Independence Mall W, Philadelphia, PA 19106, USA. 20. Department of Nursing in Collective Health, School of Nursing, University of São Paulo, São Paulo 419, Brazil. 21. Department of Social Pharmacy and Pharmaceutical Legislation, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia. 22. School of Pharmaceutical Education and Research, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India. 23. Institute of Health Information and Statistics of the Czech Republic, Palackého náměstí 375/4, 128 01 Praha 2, Czech Republic. 24. Department of Nursing and Midwifery, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic. 25. Czech Clinical Research Infrastructure Network, Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
Abstract
BACKGROUND: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. METHODS: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses' side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. CONCLUSIONS: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
BACKGROUND:Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. METHODS: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses' side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. CONCLUSIONS: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
Entities:
Keywords:
COVID-19; cohort studies; cross-sectional studies; drug-related side effects and adverse reactions; health personnel; mass vaccination; prevalence
Authors: Abanoub Riad; Anna Jouzová; Batuhan Üstün; Eliška Lagová; Lukáš Hruban; Petr Janků; Andrea Pokorná; Jitka Klugarová; Michal Koščík; Miloslav Klugar Journal: Int J Environ Res Public Health Date: 2021-12-19 Impact factor: 3.390
Authors: Anna Paczkowska; Karolina Hoffmann; Michał Michalak; Anna Hans-Wytrychowska; Wiesław Bryl; Dorota Kopciuch; Tomasz Zaprutko; Piotr Ratajczak; Elżbieta Nowakowska; Krzysztof Kus Journal: Vaccines (Basel) Date: 2022-03-12